Xilio Therapeutics Inc at Cowen IO Next Summit (Virtual) Transcript
Hi, welcome to the next session of the sixth annual Cowen IO Next Summit. We are really pleased to have with us today for the next session, Marty Huber, President and Head of R&D from Xilio Therapeutics. And I would remind all the investors on the line that while I do have a question list that I can run through with Marty, we'd love to have this be as interactive as possible. So you can submit questions either through the chat function of the webcast or you can email me directly at [email protected].
Questions & Answers
So maybe just to start off, Marty, just to level set people who may not be in depth truly familiar with Xilio, just can you give a brief overview of the GPS platform, NK, how it works, and why it's ideally suited for delivering cytokines or other biologics?
Thank you. And first of all, I'll say hello from Boston at [Fitzy]. We're actually at
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |